Immunotherapy Weekly articles from September 2004

Immunotherapy Weekly archives from September 2004

CD28 is required in the effector phase of allergic airway inflammation.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- A new study reveals a requirement for CD28 in the effector phase of allergic airway inflammation. According to a study from the United States, "Central to the pathogenesis of allergic airway...

Sinusitis, rhinosinusitis reclassified by task force as inflammatory diseases.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- A group of leading allergists and otolaryngologists recently published a paper reclassifying sinusitis and rhinosinusitis as inflammatory diseases triggered by mold and bacteria in the nose and sinuses....

Tolerance in T cells accompanied by effector function in lymphoid organs.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Oral tolerance in T cells is accompanied by induction of effector function in lymphoid organs after systemic immunization. "The physiological ramifications of oral tolerance remain poorly...

Prostaglandin E[subscript]2 receptors up-regulated in peritoneal macrophages.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Prostaglandin E[subscript]2 receptors EP2 and EP4 are up-regulated in peritoneal macrophages and joints of pristane-treated mice and modulate TNF-alpha and IL-6 production. "Prostaglandin...

Interferons effective in the treatment of severe acute respiratory syndrome.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Interferons are effective in the treatment of severe acute respiratory syndrome. "Severe acute respiratory syndrome (SARS) is caused by the SARS coronavirus (SCV). The disease appeared in the...

Challenges in the search for HIV vaccine outlined.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Researchers outline challenges in the search for an HIV vaccine in a recent issue of the European Journal of Epidemiology. "Considerable progress has been made over the past several years in the...

T cell-based control of SIV replication in AIDS vaccine trial reported.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Researchers report cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial. "Recently, encouraging AIDS vaccine trials in macaques have...

AML-associated mutant inhibits differentiation of myeloid/erythroid stem cells.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- An acute myeloid leukemia-associated mutant inhibits differentiation of myeloid/erythroid stem cells. "The CCAAT/enhancer binding protein alpha (C/EBPalpha) is an essential transcription factor for...

Clopidogrel-associated autoimmune thrombocytopenic purpura reported.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- A case of clopidogrel-associated autoimmune thrombocytopenic purpura has been reported. Physcians in the United States described their experience treating "a 51-year-old male who underwent coronary...

President Bush signs bill that will benefit millions with food allergies.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- The Food Allergy Initiative celebrates a major victory in its public policy campaign as President George W. Bush signed the Food Allergen Labeling and Consumer Protection Act (S. 741) into law. The...

Children with serious insect-sting allergies should get shots.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Children who have severe allergic reactions when stung by bees, wasps and other insects should receive venom immunotherapy, or allergy shots, to reduce the chance of future life-threatening reactions if...

Group neutralizes allergy-causing protein.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Israeli scientists have found a way to neutralize a sesame seed protein that causes allergies using a technique that could eliminate allergens in milk and other common foods, Israel's leading technical...

Quaternary ammonium compounds exhibit adjuvant effect in murine model.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Quaternary ammonium compounds exhibit an adjuvant effect in a murine model. "It has been suggested that occupational exposure to quaternary ammonium compounds (QACs) may promote the development of...

Amyloid accumulation in Alzheimer disease is response to chronic stress.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Amyloid accumulation in Alzheimer disease is a response to chronic stress. "Amyloid deposition within cerebral vessels, or cerebral amyloid angiopathy (CAA), is common in advanced age and even more...

Testing of Alzheimer vaccines needed in non-murine models.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Alzheimer vaccines must be thoroughly tested in non-murine animal models before trials begin in humans. According to a study from Australia and the United States, "Recent clinical and...

CHIP promotes proteasomal degradation of familial ALS-linked mutant.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Researchers from Japan report that carboxyl terminus of the Hsc70-interacting protein (CHIP) promotes proteasomal degradation of familial amyotrophic lateral sclerosis (ALS) -linked mutant SOD1 by...

Sustained benefit of HAART lost when prisoners return to community.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- The sustained benefit of highly active antiretroviral therapy is lost when HIV-1-infected prisoners return to the community. "Responses to highly active antiretroviral therapy (HAART) in...

Systemic lupus erythematosus patients are at high risk for thromboembolism.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Factor V Leiden and the prothrombin mutation contribute to the risk of venous thromboembolism (VTE) in patients with systemic lupus erythematosus (SLE), researchers say. According to a study from...

Monitoring during pregnancy helps prevent serious exacerbations of asthma.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- According to asthma specialists, "The course of asthma during pregnancy is variable. When the total pregnant asthmatic population is considered, one-third improve, one-third are unchanged, and one-third...

tetR real-time PCR detects and quantifies tetracycline-resistant bacteria.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- A tetR real-time PCR assay detects and quantifies tetracycline-resistant bacteria. According to recent research published in the Journal of Biochemical and Biophysical Methods, "Bacteria of implant...

Immune vaccine followed by chemotherapy slows incurable brain tumors.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that the combination of immunotherapy and chemotherapy significantly slowed tumor progression and extended survival of...

Farnesyl transferase inhibitors show promise as therapies for breast cancer.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Farnesyl transferase inhibitors show promise as targeted therapies for breast cancer. According to recent research published in the journal Endocrine-Related Cancer, "The ras family of...

Peptides inducing immune responses in breast cancer patients identified.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Scientists have identified HER2/neu-derived peptides capable of inducing both cellular and humoral immune responses in HLA-A24 positive breast cancer patients. "HRE2/neu-specific cellular and...

Tamoxifen and soluble tumor-associated antigens suppress breast cancer.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Treatment with tamoxifen and soluble tumor-associated antigens stimulate T- and B-lymphocyte responses to breast cancer tumors. According to recent research published in the journal Oncology...

Tissue inhibitors of MMPs increased in women with capsular contracture.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- According to a study by plastic surgeons, tissue inhibitors of metalloproteinases are increased in women with capsular contracture after insertion of breast implants. "In various fibrotic diseases,...

Vaccine protects mice against virulent Brucella melitensis.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Oral vaccination with Brucella melitensis WR201 protects mice against intranasal challenge with virulent Brucella melitensis 16M. "Human brucellosis can be acquired from infected animal tissues by...

Company reports strong Cialis sales, updates second quarter.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- ICOS Corp. (ICOS) released its financial results for the 3 and 6 months ended June 30, 2004, and summarized recent events. During the 2004 second quarter, worldwide sales of Cialis, a treatment for...

Life sciences company reports on second quarter 2004 results.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- ProMetic Life Sciences Inc. (TSX: PLI) reported on its business and financial results for the second quarter ended June 30, 2004. - Human cytotoxic T lymphocites (CTL) stimulated by PBI-1393 proven...

LymphoStat-B maker reports losses, milestones in Q2 2004.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Human Genome Sciences, Inc., (HGSI) announced financial results for the 3-month and 6-month periods ended June 30, 2004. The company's actual net loss for the quarter ended June 30, 2004, in...

Pharma company reports second quarter 2004 results.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Point Therapeutics, Inc., (NASDAQ: POTP) reported results for the fiscal quarter and 6 months ended June 30, 2004. During the second quarter of 2004, Point achieved the following key milestones:...

Lentiviral transfection of dendritic cells upregulates alloreactive T cells.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Lentiviral transfection of dendritic cells upregulates alloreactive T cells. According to recent research from Japan, "gene-modified dendritic cells (DCs) are promising targets for cancer...

Immunoconjugates improve targeting of photosensitizers.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Intratumoral administration of immunoconjugates improve the targeting of photosensitizers. According to published research from India, "Biodistribution of technetium (99mTc) labeled hematoporphyrin...

Independent laboratory and Merck & Co., Inc., sign oncology research partnership.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Pierre Fabre Medicament has signed a collaborative research, development and license agreement with Merck & Co., Inc., for F50035, Pierre Fabre Medicament's recombinant humanized antibody targeted...

Pharma company announces publication of study examining Talabostat.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Point Therapeutics, Inc., (NASDAQ: POTP) announced that a study investigating its lead product candidate talabostat (PT-100) has been published in the August edition of Cancer Research. The study...

Positive data reported at ASCO on T-cell-guided therapy.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Danish biotech company T-cellic demonstrated that their specific T-cells can act as carriers of compounds in the localization and treatment of cancer tumors and metastases, when early data was presented...

Antigen-loading strategies of dendritic cells for cancer vaccines compared.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Investigators compare antigen-loading strategies of dendritic cells for tumor immunotherapy in a recent issue of the Journal of Immunotherapy. "Dendritic cells (DCs) loaded with antigens can...

CD4+ responses identified in patient vaccinated with NY-ESO-1.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Scientists have identified immunodominant CD4+ responses in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant. According to recent research from Australia, "There is...

Epithelial cancer-related antigens applicable for peptide-based immunotherapy.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Investigators review the expression of epithelial cancer-related antigens in hematologic malignancies applicable for peptide-based immunotherapy in a recent issue of the Journal of Immunotherapy. ...

Exosomes from plasmacytoma cells show promise as tumor vaccine.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Exosomes from plasmacytoma cells show promise as a tumor vaccine. "Exosomes are membrane-bound vesicles derived from multivesicular bodies that are externalized by cells through fusion with the...

Monoclonal antibodies recognize idiotypic immunoglobulins of lymphoma cells.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Human monoclonal antibodies produced in transgenic BABK kappa,lambda mice recognize idiotypic immunoglobulins of human lymphoma cells. According to a study from Spain, "Clonal idiotypic...

Thymus-leukemia antigen acts as tumor-specific antigen.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Researchers are investigating thymus-leukemia antigen (TL) as a major histocompatibility complex (MHC) class lb molecule and tumor-specific antigen. According to recent research from Japan, "Mouse...

Viral chemokine fusions trigger antitumor immunity independent of chemotaxis.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis. "The ideal vaccine carrier should be able to target antigen...

Iron absorption is upregulated in celiac patients as a result of iron deficiency.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Adaptive changes of duodenal iron transport proteins in celiac disease are studied. According to recent research from Italy, "Iron deficiency is a manifestation of celiac disease (CD) usually...

Trypomastigote challenge of T. cruzi infected mice reduces parasitemia.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- A challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels. According to recent research from Brazil,...

V. cholerae polysaccharide fragments are immunogenic in mice.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Synthetic fragments of Vibrio cholerae O1 inaba O-specific polysaccharide bound to a protein carrier are immunogenic in mice but do not induce protective antibodies. According to a study from the...

Child with atypical CML treated successfully with imatinib mesylate.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- A child with atypical chronic myelogenous leukemia was treated successfully with imatinib mesylate. "Atypical chronic myelogenous leukemia (aCML) is a myelodysplastic/myeloproliferative disorder...

Jubilant Biosys and visual informatics software provider partner.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- OmniViz, Inc., and Jubilant Biosys announced their collaborative effort to make Jubilant Biosys content deployable within the OmniViz Pathway Enterprise (OPE) software. OPE is a full-featured...

SARS-CoV entry suppressed by peptides corresponding to HR on spike glycoprotein.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- SARS-CoV entry is suppressed by peptides corresponding to heptad repeat regions on spike glycoprotein. According to published research from China, "Heptad repeat regions (HR1 and HR2) are highly...

SARS-CoV follows the general fusion mechanism of class I viruses.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- SARS-coronavirus follows the general fusion mechanism of class I viruses. "Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) is a newly identified member of Family Coronaviridae,"...

Antibodies to Cryptococcus neoformans infection are nonprotective.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Antibodies produced in response to Cryptococcus neoformans pulmonary infection in mice have characteristics of nonprotective antibodies. According to published research from the United States,...

Gender differences exist in cytokine secretion from cytomegalovirus infection.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Gender differences exist in cytokine secretion resulting from cytomegalovirus infection. According to recent research from the United States, "Cell-mediated memory immune responses to viral antigens...

CD8+ T-cell immunity to cytomegalovirus reviewed.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Researchers review CD8+ T-cell immunity to cytomegalovirus in a recent issue of Human Immunology. "Cytomegalovirus is arguable the most immunodominant antigen that is encountered by the human...

Cytomegalovirus-specific cellular immune responses reviewed.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Researchers review cytomegalovirus-specific cellular immune responses in a recent issue of Human Immunology. According to recent research from Switzerland, "A large percentage of healthy...

Lentiviral vector encoding cytomegalovirus protein identifies epitopes.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Investigators have used a lentiviral vector encoding a human cytomegalovirus chimeric IE1-pp65 protein for epitope identification in HLA-transgenic mice. "H2-deleted, HLA-A2, or HLA-B7 transgenic...

Progress being made toward developing cytomegalovirus peptide vaccine.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Progress is being made toward developing a cytomegalovirus peptide vaccine. "Cytomegalovirus disease still remains a major cause of morbidity and mortality in hematopoietic stem cell transplantation...

Epstein-Barr virus in saliva may reflect status of periodontal inflammation.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Epstein-Barr virus (EBV) in saliva may reflect the status of periodontal inflammation. According to recent research from Japan, "The purpose of this investigation was to assess the salivary levels...

U.S. FDA clearance given for herpes simplex virus assay.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Trinity Biotech plc (TRIB) announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to market its Captia HSV IgG Type Specific ELISAs in the United States. These...

Protein, peptide and non-peptide drug PEGylation for therapeutic application.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Researchers have found that protein, peptide and non-peptide drug PEGylation may be effective for therapeutic applications. According to a study from Italy, "For many years proteins have been...

Positive results reported: Electroporation-enabled DNA delivery sans anesthesia.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Genetronics Biomedical Corp.Bernie Hertel, +1-858-410-3101 Genetronics Biomedical Corp. (GEB), a late-stage developer of cancer and other therapies using electroporation-enabled delivery of drugs,...

Biopharmaceutical company initiates clinical trial of TRX4 for psoriasis.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- TolerRx, Inc., a biopharmaceutical company, announced the initiation of a phase 1 trial of its TRX4 monoclonal antibody in subjects with psoriasis. This phase 1 trial will be a single-dose,...

Genetics company announces enrollment for South African clinical trial of VGV-1.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Viral Genetics, Inc. (VRAL) announced that enrollment has begun for a human clinical trial in South Africa on VGV-1. VGV-1, formerly known as thymus nuclear protein, is a purified protein extracted...

Novel oxoamides inhibit group IVA cytosolic phospholipase A[subscript]2.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- A series of oxoamides inhibit group IVA cytosolic phospholipase A[subscript]2, and the mechanics of this effects have been characterized in vitro and in vivo. "The Group IVA cytosolic phospholipase...

Proteomics company to provide services for Intra-Cellular Therapies.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Shamrock Structures, Woodridge, Illinois, has signed an agreement with Intra-Cellular Therapies, Inc. (ITI), a New York City-based biopharmaceutical company, to provide integrated structural proteomics...

Type I receptor kinase inhibitors block cellular TGF-beta signaling.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- A series of type I receptor kinase inhibitors block cellular transforming growth factor (TGF)-beta signaling. TGF-beta is "a 25-kDa dimeric polypeptide that plays a key role in a variety of...

U.S. FDA approves new drug application for generic topical cortisone ointment.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Taro Pharmaceutical Industries Ltd. (TARO) reported that its U.S. affiliate has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for...

U.S. patent more broadly protects Transfluor compositions of matter technology.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Norak Biosciences, Inc. announced a newly issued U.S. patent covering compositions of matter that more broadly protect its Transfluor technology. The newly issued U.S. Patent No. 6,770,449 claims...

ETS transcription factor GABP alpha essential for early embryogenesis.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- The ETS transcription factor GABP alpha is essential for early embryogenesis. "The ETS transcription factor complex GABP consists of the GABPalpha protein containing an ETS DNA binding domain, and...

pRb and p107 play a central role in regulating epidermal homeostasis.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- pRb and p107 play a central role in regulating epidermal homeostasis. According to published research from the Netherlands, "The retinoblastoma gene product, pRb, plays a crucial role in cell cycle...

Embryos constructed through somatic cell nuclear transfer.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Embryos were constructed through somatic cell nuclear transfer. According to recent research from Singapore, "Production of genetically identical non-human primates through somatic cell nuclear...

Entamoeba lectin epitopes recognized by human IgA antibodies identified.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Researchers have identified the Entamoeba histolytica galactose-inhibitable lectin epitopes recognized by human immunoglobulin A antibodies following cure of amebic liver abscess. "Immunity to...

Immunomagnetic separation detects and counts parasites in sewage sludge samples.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Immunomagnetic separation combined with indirect immunofluorescence assay is used to detect and enumere Cryptosporidium oocysts in sewage sludge samples from the city of Florianopolis (Brazil). ...

Tobacco industry attempted to influence reporting on secondhand smoke.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- A study based on the tobacco industry's own documents shows the extent of the tobacco industry's efforts to influence the print media on the health effects of secondhand smoke. This study was...

Evolution of Epstein-Barr virus-encoded oncogene LMP1 studied.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Researchers reported on the selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from southeast Asia. According to a study from Australia, "The...

P16(INK4A) status independent of EBV-induced cell proliferation and latency.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- P16(INK4A) status is independent of EBV-induced cell proliferation and latency. "Epstein-Barr virus (EBV) has the ability to promote cell cycle progression following the initial infection of primary...

Alferon N maker announces private placement of common stock and warrants.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Hemispherx Biopharma, Inc., (HEB) has entered into definitive agreements with selected accredited institutional investors, including current shareholders, relating to a private placement of...

Antibody maker completes round of private financing.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Elusys Therapeutics, Inc., has successfully completed a private placement of series D preferred stock, raising more than $10 million. Proceeds from the financing will be used to further develop the...

Biopharmaceutical company raises $7.5 million in private financing.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Pepgen Corporation announced that it successfully completed a preferred stock financing, raising just over $7.5 million. Toucan Capital led the round of funding with participation from...

Cubicin maker reports increased Q2 revenues.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Cubist Pharmaceuticals, Inc., (CBST) reported results for the second quarter ended June 30, 2004. During the second full quarter since launch, Cubist achieved $13.3 million in revenue for its...

Drugmaker provides Q2 update, reports net loss.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- CuraGen Corp. (CRGN) reported financial results for the second quarter ended June 30, 2004. CuraGen continued to advance its downstream drug-development efforts while managing overall expenditures....

Immunotherapy company's second-quarter revenue dips.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Corixa Corp. (CRXA), a developer of immunotherapeutics, announced financial results for the second quarter ended June 30, 2004. For the second quarter of 2004 Corixa reported total revenue of $5.8...

Oncology-focused biopharma reports record product revenues Q2 2004.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Cytogen Corp. sshearer@cytogen.com Cytogen Corp. (CYTO), a product-driven, oncology-focused biopharmaceutical company, reported its consolidated financial results for the second quarter and 6...

Pharma company announces second quarter 2004 financial results.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Rigel Pharmaceuticals, Inc., (NASDAQ:RIGL) reported financial results for the second quarter and 6 months ended June 30, 2004. For the second quarter of 2004, Rigel reported a net loss of $12.3...

Pharma company reports second quarter 2004 financial results.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Renovis, Inc., (NASDAQ:RNVS) announced financial results for the quarter ended June 30, 2004. Revenue for the quarter and 6-months ended June 30, 2004, was $656,000 and $1.3 million, respectively,...

Third installment of $3 million dollars received for shares of biopolymer stock.
September 1, 2004... 2004 SEP 1 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) has received the third of four $3 million payments from James Dicke II and his son James Dicke III. As announced, on February 3, 2004, ADVR entered into an...